In late 2015, Gideon started to fuss more than usual. His parents, Katie and Gary, assumed he was teething. When Gideon developed bruises above his eyes and a lump on his head, they became alarmed.
Tests soon revealed Gideon suffered from stage IV neuroblastoma, a type of cancerous tumor.
At St. Jude Children’s Research Hospital, Gideon’s treatment included surgery to remove the primary tumor, a bone marrow transplant, radiation therapy and an antibody therapy manufactured right on the St. Jude campus in Memphis, Tenn.
We were scared to death when we first got here. Looking at my sweet little baby and thinking about losing him was unthinkable.
Treatments invented at St. Jude have helped push the overall childhood cancer survival rate from 20% to more than 80% since it opened more than 50 years ago.
Gideon completed treatment in early 2017 and now visits St. Jude for yearly appointments. He loves all things sports and will start playing t-ball soon.
Gideon is also excited about becoming a big brother when his mom gives birth to a baby girl this fall.